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1. Introduction 
A carrier system for the transport of choline into 
synaptosomes has been demonstrated by several inves- 
tigators [l-3] . Recently, evidence has been presented 
for the existence of high and low affinity components 
in this transport system [4-81 . The high affinity com- 
ponent is Na+-dependent [4,7] , is competitively in- 
hibited by hemicholinium-3 [S, 61, and appears to be 
that which supports acetylcholine (ACh) synthesis 
[4,7,8] . The latter observation suggests that the trans- 
port of choline by the high affinity system may be 
linked to the activity of choline acetyltransferase 
(ChAc, EC 2.3.1.6). To test this hypothesis we have in- 
vestigated the effect of naphthylvinylpyridinium inhib- 
itors of ChAc on the synaptosomal uptake of choline. 
Aside from being inhibitors of ChAc, these agents in- 
hibit drug metabolizing enzymes [9] , potentiate the 
excitatory effects of amphetamines [9] , and impair 
passive avoidance behavior [lo] . Although these 
agents are potent in vitro inhibitors of ChAc, they do 
not decrease whole brain or hippocampal levels of 
ACh [lo-121. 
Naphthylvinylpyridinium agents inhibit synaptoso- 
ma1 choline uptake. The mechanism of inhibition ap- 
pears to be independent of an action on ChAc. 
2. Materials and methods 
All chemicals used were reagent grade. N-methyl- 
[3H]choline, S.A. 16Ci/mM, was purchased from 
Amersham/Searle and purified by chromatography on 
North-Holland Publishing Company - Amsterdam 
Sephadex SE-25 (Pharmacia). Naphthylvinylpyridine 
HCl, methiodide and N-hydroxyethyl bromide were 
synthesized by the method of Cavalitto et al. [13,14] . 
Hemicholinium-3 was generously provided by 
Dr. V.B. Haarstad, Department of Pharmacology, 
Tulane University, New Orleans, La, USA. 
2.1. Isolation of synaptosomes 
A crude synaptosomal fraction was isolated from 
rat forebrain as described by Whittaker and Barker 
PSI * 
2.2. Synaptosomal uptake of ( 3H]choline 
The crude synaptosomal fraction was used without 
further purification since several investigators have 
shown that choline uptake by this fraction is primarily 
due to synaptosomes [ 1,4,7,8] . Synaptosomes from 
20 mg tissue (1200 pg protein) were suspended in 1 
ml of Krebs-Ringer phosphate buffer (pH 7.5) [ 161, 
containing 5 nmol of [3H]choline (S.A. 0.17 or 1 pCi/ 
nmol). The choline concentration (5 X 10s6 M) se- 
lected was one in which choline uptake by the high 
and low affinity components would be approximately 
equal [7,8] . Incubations were initiated by transferring 
the tubes to a 37°C water bath and terminated after 5 
min by transfer to an ice bath. Synaptosomes from 4 
or 8 mg tissue were collected on a 25 mm Millipore cel- 
lulose acetate filter (0.8 /J) and washed with 10 ml of 
ice cold Krebs-Ringer phosphate buffer. The filters 
were transferred to scintillation vials and solubilized 
with 1 ml of cellosolve. Ten ml of Triton X-lOO-tolu- 
ene cocktaile [ 171 were added and the samples were 
counted in a Beckman liquid scintillation spectrometer 
141 
Volume 35, number 1 FEBS LETTERS September 1973 
Table 1 
Inhibition of synaptosomal [3H]choline uptake by hemicho- 
linium-3 and napththylvinylpyridiniums*. 
Drug** Concn. 
(PM) 
Uptake*** 
Percent Ki**** 
inhibition ChAc 
Control - 889.5 0 _ 
HC-3 50 139.1 82 - 
NVP 50 323.0 64 2.2 x lo-5 
NVPM 50 300.0 66 3.3 x 1o-6 
NVPH 50 441.5 51 1 x 1o-6 
* Activity determined as described in text. 
** Abbreviations: hemicholinium-3, HC-3; naphthylvinyl- 
pyridine HCI, NW; naphthylvinylpyridinium methiodide, 
NVPM; hydroxyethyI-naphthylvinylpyridinium bromide, 
NVPH. 
*** dpm/mg Tissue/5 min. The specific activity of [3H] cho- 
line was 0.17 crCi/nmol. 
**** From Cavallito et al. [ 13,141. 
In some experiments synaptosomes from 100 mg of 
tissue were incubated in 5 ml of buffer as described 
above and isolated by centrifugation at 340 000 g/ 
mm. The [3H]ACh and [3H]choline in the pellet 
were extracted, separated, and determined as de- 
scribed by Barker et al. [ 171. Non-specific and diffu- 
sional uptake were corrected by subtracting values ob- 
tained at 0°C from those at 37°C. 
2.3. Analytical procedures 
Protein was determined by the method of Lowry 
et al. [ 181, using bovine serum albumin as a standard. 
3. Results 
The choline acetyltransferase inhibitors, naphthyl- 
vinylpyridine (VNP), naphthylvinylpyridinium meth- 
iodide (NVPM) and hydroxyethyl-naphthyl-vinylpyri- 
dine bromide (NVPH) inhibit the uptake of [3H]cho- 
line by synaptosomes. Initial experiments (table 1) 
showed the order of inhibitory effect of NVPM > 
NVP> NVPH; but all were less potent than hemicho- 
linium3 (HC-3). Subsequent experiments dealt only 
with NVPH and HC-3. In fig. 1, the ability of NVPH 
to block [3H] choline uptake is compared to that of 
HC-3 over a wide dose range. As in the initial experi- 
ments, it is seen HC-3 is much more potent than 
NVPH. Also the shape of the log dose-response 
curves are very different. With HC-3 at I-10pM the 
inhibition is relatively constant, around 60%-70%. 
The Ki for HC-3 on the high affinity component has 
been reported to be 0.05-0.1 PM [4]. Thus at the 
lowest concentration of HC-3 (1 PM), used here, the 
high affinity transport component should be com- 
pletely blocked. The 15o to inhibit the remaining 40% 
1 I 
1.0 10.0 100.0 l000.0 
EII * JIM 
Fig. 1. Inhibition of [3H]choline uptake by NVPH (0) and HC-3 (x). Values are mean f SEM (N= 3). Control uptake was 
10 100 i 74 dpm/mg tissue/5 min. The specific activity of [3H]choline was lr.~Ci/nmol. 
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Table 2 
Inhibition of synaptosomal r3H]choline uptake 
and [ 3H]acetylcholine synthesis*. 
Drug 
[3H]ChoJine [‘H]Acetyl- 
Concn. Uptake** choline synthesis 
** 
(PM) 
Experiment 1 *** 
Control - 342.3 f 23.8 104.3 f 7.7 
HC-3 10 44.4* 9.6 0.1 f 0.3 
NVPH 20 148.6 * 48.1 90.5 f 2.0 
Experiment 2 
Control 353.2* 21.0 89.3 + 1.7 
NVPH 20 223.2 f 19.0 67.9 f 2.2 
* Activity determined as described in text. Data are mean f 
SEM (N = 3). 
** dpm/mg Tissue/S min. Specific activity of choline was 
0.17 pCi/nmol. 
*** Physostigmine (5 X 10b4M) present in extractant for ex- 
periment 1, but not for experiment 2. 
of the uptake, presumably that due to the low affmi- 
ty component, is about 45 PM, in good agreement 
with a value of 50 PM, reported by Haga and Noda 
[4] for the Na+-independent (low affinity) compo- 
nent of choline transport. In contrast, the inhibition 
produced by NVPH from 2-200 /.LM increases in an 
apparent linear manner with the log of the dose at the 
concentration of choline used in these experiments. 
In table 2 the effect of NVPH and HC-3 on trans- 
port of [3H]choline and formation of [3H]acetylcho- 
line is shown. Here it is seen that NVPH at 20 (uM is 
more effective in blocking [3H] choline uptake than 
it is in blocking the formation of [3H]ACh. With HC- 
3 at 10 PM, there was no detectable formation of 
[3H]ACh, as would be expected for a complete inhibi- 
tion of the high affinity uptake system [4,7,8] . 
4. Discussion 
The naphthylvinylpyridinium inhibitors of ChAc 
block synaptosomal uptake of choline by a means 
which appears to be unrelated to their ability to inhib- 
it ChAc in vitro. Firstly the potency in blocking up- 
take does notparallel their ability to inhibit ChAc 
(table 1). Secondly, the inhibition curves (fig. 1) 
show that NVPH blocks both the high and low affinity 
components of the choline transport system. The 
greater inhibition of choline transport compared to 
choline incorporation into ACh (table 2) indicates 
some selectivity in blocking the low affinity compo- 
nent. By contrast, with HC-3 the reverse obtains, i.e., 
blockade of choline uptake is equal to or less than 
the block of ACh synthesis [4] because HC-3 is selec- 
tive for the high affinity uptake component [4,6]. 
Further, since the formation of ACh by synapto- 
somes is only slightly inhibited by NVPH at 20 /.IM 
(20 X the Ki for ChAc) [ 131, it would appear that 
the synaptosomal membrane is relatively impermeable 
to NVPH. This may be the reason why NVPM [lo] 
and its analogs [ 11,121 fail to decrease brain levels 
of ACh. 
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